Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index; 11 of the 26 sources its claims cite were checked for support.
Abstract
Compared to national figures, all disorders were associated with substantially lower life expectancy: 8.0 to 14.6 life years lost for men and 9.8 to 17.5 life years lost for women. Highest reductions were found for men with schizophrenia (14.6 years lost) and women with schizoaffective disorders (17.5 years lost).
Overview
CoChat Summary
TL;DR
Using a large South London mental health case register linked to national mortality data, the paper estimates markedly reduced life expectancy at birth for people with serious mental illness and related disorders. The largest losses were 14.6 years for men with schizophrenia and 17.5 years for women with schizoaffective disorder.
Key findings
- Among 31,719 eligible people aged 15+ with SMI, 1,370 died during 2007–09.
- Compared with national figures, all disorders were associated with 8.0 to 14.6 life years lost for men and 9.8 to 17.5 life years lost for women.
- The greatest reductions were 14.6 years lost for men with schizophrenia and 17.5 years lost for women with schizoaffective disorders.
- In the analyzed sample, life expectancy at birth ranged from 62.8 years (men with schizophrenia) to 69.4 years (men with schizoaffective disorder), and from 64.1 years (women with schizoaffective disorder) to 74.4 years (women with depressive disorders).
Methods
- Retrospective register-based analysis using the SLAM Case Register Interactive Search (CRIS), a secondary mental health care database covering southeast London.
- Included people diagnosed before end-2009 with schizophrenia, schizoaffective disorder, bipolar disorder, substance use disorder, depressive episode, or recurrent depressive disorder and under active review during 2007–09; final analytic sample was 31,719 people aged 15+.
- Estimated life expectancy at birth by gender and diagnosis using national mortality returns (2007–09) and Chiang’s abridged life table method in 5-year age groups.
Limitations
- The authors state that the secondary healthcare setting may limit generalizability, especially for substance use disorders and depressive disorders, because register cases are likely a more severe and unrepresentative subset of community cases.
- Diagnostic categories overlapped, but the study analyzed disorders separately; the paper says comorbidity between SMI and substance use disorders should not be assumed to be captured because source data reflected primary diagnoses rather than co-occurrence.
- Evident from the text: the study uses administrative/register data and compares to national norms, so it cannot fully disentangle causal pathways or all confounding factors behind the mortality differences.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
7 Valid · 1 Not valid · 10 Not checked · 19 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Despite healthcare improvements, there has been little evidence of benefit on life expectancy in people with SMI [1], [20], [21]”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Introduction Concerns about premature mortality among people with mental disorders have been increasing [1]–[6]. Higher general and specific causes of mortality in all or specific age groups have been identified for people with serious mental illnesses (SMI, which might include schizophrenia, schizoaffective disorder, bipolar disorder, and depressive psychosis) in a range of settings [1], [2], [7]–[11], although most report relative risks or rates of mortality rather than life expectancy – which is arguably a more important index for shaping policy since it takes premature mortality into account and has been widely used for other risk exposures such as smoking, diabetes, obesity, ethnicity and socioeconomic status [12]–[17]. Of the few studies to measure this outcome, clients with SMI from public mental health agencies in eight US states from 1997 to 2000 were found to have lower life expectancies of 13 to more than 30 years compared to the general population (depending on the year and state) [2], and a loss of 8.8 life years (14.1 years for men and 5.7 years for women) was estimated in a comparison between people treated for SMI and the general population in Massachusetts, US [1]. A Swedish study using a nationwide hospital discharge registry reported substantial gaps in life expectancy at age 30 for main mental disorder categories compared to the general population, particularly for functional psychosis other than schizophrenia / affective psychosis (15.9 years lost), substance abuse (15.6 years lost), and organic psychosis (14.8 years lost) among men and organic psychosis (22.6 years lost), mental retardation (14.7 years lost), and substance abuse (18.8 years lost) among women [18]. Preliminary strategies for preventing premature deaths among people with SMI have been suggested, emphasizing the management of suicide risk and physical illness, minimum polypharmacy, and improvement of accessibility to physical health care [19]. Despite healthcare improvements, there has been little evidence of benefit on life expectancy in people with SMI [1], [20], [21], and further research is urgently required [22]. We reported excess mortality for people with diagnoses of SMI, as well as for depressive and substance use disorders, drawing on data from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) Case Register, which covers comprehensive secondary mental healthcare provision to a large geographically defined community, by standardized mortality ratios (SMRs) [23]. Nonetheless, equal weighting is used for each age group in the calculation of SMRs, which is insufficient for highlighting the impact of premature mortality among younger age groups in the study cohort.
What the sources say
- Not checked — no full text of the sourcecites [1] BP Dembling, 1999, Life expectancy and causes of death in a population treated for serious mental illness., Psychiatr Serv source
- Supportedcites [20] R Gray, 2009, Physical health and severe mental illness: if we don't do something about it, who will?, Int J Ment Health Nurs source
The opening discussion states that life expectancy for people with severe mental illness is decreasing, supporting the claim that it has shown little benefit. The discussion of interventions describes improvements in physical-health risk factors but says only a minority of patients receive them. Page numbers are not provided in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [21] LA Chwastiak, 2009, The unchanging mortality gap for people with schizophrenia., Lancet source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, in a sensitivity analysis of SMR data, the use of London comparators did not meaningfully change findings [23].”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Discussion Using a large secondary mental healthcare database in southeast London linked to national mortality returns, we confirmed substantially shortened life expectancies at birth for all serious mental disorder groups investigated compared to national norms. Largest reductions were found for men with schizophrenia, women with schizoaffective disorders, and both men and women with substance use disorders. In previous analyses of these cohorts, raised standardised mortality ratios (SMRs) had been described [23], although the picture was less dramatic because SMRs reflect less well the impact of premature mortality at earlier life stages. In a US study conducted by the Massachusetts Department of Mental Health from 1989 to 1994, service users with SMI were found to have lost 8.8 years of potential life (14.1 years for men and 5.7 for women) on average compared to the general population, a stronger impact for men and weaker impact for women compared to findings from our sample. However, SMI was not specifically defined in the Massachusetts study other than stating “evidence of serious dysfunction” as an inclusion criterion [1], which might explain the discrepancy. A Swedish analysis of national discharges from 1978–82 reported more complex data on life expectations at given ages. For the lowest age described (30 years), subsequent life expectancy associated with schizophrenia was 7.9 years lower in men and 9.5 years lower in women [18] – i.e. similar to the finding for women in our sample but less strong for men. Further international research is clearly required to compare the potential impacts of SMI on life expectancy in different settings since this may provide clues as to systems of care which may help to maximise this. Mortality in SMI is recognised to be raised and underlying causes may be multiple. As well as our own findings, any psychiatric diagnosis was associated with a 65% higher than expected total mortality in a case register study in a British primary care cohort [30]. In the same setting, a three-fold elevated mortality was found for coronary heart disease in young adults with SMI, and a more than two-fold increased mortality of stroke in all age groups [8]. Long-term antipsychotic use and adverse lifestyle choices (e.g. obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3], [19], [20], [22], [31]–[33] and clearly need higher levels of consideration in order to improve health and survival, as well as the better-known risks of suicide and violent deaths. Because the causal pathways between mental disorder and premature mortality are multiple, and because life years lost as an outcome measures not only the effect of an exposure on risk of mortality but also its differential effect across the age range, it is difficult to interpret with certainty the gender variation in findings – i.e. the strongest effects of schizophrenia in men and schizoaffective disorder in women. Clearly the two disorders overlap substantially at a genetic and biological level. It is possible that the impact of co-occurring affective disorder is stronger in women due to specific biological or social vulnerability. However, against this, there was no difference in the impact of bipolar disorder between men and women and the impact of depressive episode/disorder was stronger in men. Alternative explanations may lie in the clinical practice of assigning diagnoses and gender differences here – for example, if there was preferential inclusion in women of severe personality disorders with transient psychotic episodes within this diagnostic group. Further research is clearly required to clarify this issue. Life expectancy is a commonly used indicator for how longevity may be impaired by specific long-term exposures (e.g. smoking, obesity, ethnicity, and socioeconomic status) or chronic states of ill-health or risk (e.g. diabetes mellitus) [12], [13], [15]–[17], [34], and provides an alternative platform to discriminate the influences of different exposures for the purpose of highlighting premature mortality at younger ages in potentially vulnerable groups [25]. It is therefore primarily a measure of impact and should be seen as complementary to more common studies using measures of effect, such as SMR statistics. As a measure, life expectancy analyses provide an important means of communicating impact on survival to policy makers and lay audiences. This approach also allows the impact of different exposures to be compared in a way which cannot be inferred from SMR outputs. As a case in point, considering the impact of other well-recognised exposures and comparing these with the potential impact of SMI, in a Japanese study of life expectancy from age 40, smoking was the most important predictor of six lifestyle related exposures (smoking, alcohol consumption, walking duration, sleep duration, consumption of green leafy vegetables, and obesity), current smoking being associated with around four to five life years lost for both genders [12], [13]. Considering 2005 life expectancy levels in the USA (75.1 years for men and 80.3 years for women), current and previous smoking was associated with 2.5 years lower life expectancy for men and 1.8 years lower life expectancy for women [17]. For British doctors born in 1900–1930 and followed up for fifty years, continued smoking was associated with around 10 years life lost, compared to lifelong non-smokers [16], and in New Zealand Census records in 1996, the gap in life expectancy between current and never smokers was 7.6 years in men and 6.7 for women [15]. Diabetes was reported to reduce life expectancy at age 15 by 1.3 years for men and 2.0 years for women in Canada [14], and a BMI of 40–45 kg/m2 was associated with a 10 year reduction of life expectancy at age 35 compared to a BMI 22.5–25 kg/m2 [35]. The potential impact of having a serious mental illness (or a substance use disorder or a depressive episode requiring secondary care contact) on life expectancy is therefore at least comparable and at worse substantially higher than effects of individual well-recognised exposures, although clearly the mechanisms through which mental disorders are associated with premature mortality will include the effects of these individual risk factors (for example, smoking behaviour, risk of diabetes, etc.) as well as other factors (such as risk of suicide or accidents and direct effects of mental distress on cardiovascular risk). Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3], [5], [30], [31], [36]–[38], although mental health service provision is often focused on preventing more rare outcomes of suicide and violent death [39]–[41]. If improving overall survival is to be considered as an alternative priority, much more efforts are clearly required to address the challenges of improving general health in people with mental disorders through medical services, socioeconomic support, and physical health promotion strategies [19]. Strengths of the study described include the large sample size and nationwide coverage of mortality, as well as the context of complete electronic clinical records. Potential limitations include the secondary healthcare setting; this should present no problem for high penetrance disorders, such as schizophrenia and bipolar disorder, where most cases will have received secondary care input. However, findings for substance use disorders and depressive disorders should be viewed with circumspection since those appearing on a secondary care register are likely to be an unrepresentative (and probably more severe) subset of community cases. Ultimately, the findings for life expectancy should be taken as referring to people with these mental disorders who had made contact with secondary mental health services within the given time period and are not necessarily applicable to all cases in a given community. Diagnostic categories overlapped, but only a minority (5.7%) of people had received more than one mental disorder diagnosis during the surveillance period. Nevertheless, comorbidity between SMI and substance use disorders should not be assumed to be captured as the source data reflected primary diagnoses rather than co-occurrence. Also we did not attempt to capture co-occurring or changing diagnoses which present potentially complex issues for analysis in a secondary care sample and which we felt were beyond the scope of this initial report. Although SLAM is a major academic as well as clinical centre, mental disorders on the Case Register are likely to be broadly generalizable to other urban settings in the UK (the SLAM catchment covers a range of residence areas from inner city to suburban settings but does not include any rural areas). Life expectancy comparisons of regional data to national norms may be problematic. However, in a sensitivity analysis of SMR data, the use of London comparators did not meaningfully change findings [23]. Also, from administrative data, life expectancy at birth for population of the four catchment area boroughs in 2007–09 (ranging from 76.3–79.5 years for males and 81.1–82.9 years for females), were not substantially different to national estimates [42]. Our results demonstrate the substantial impact of serious mental illness on life expectancy and highlight importance of developing strategies to prevent premature mortality among people with SMI and other major mental disorders. Although the prevention of suicides and violent deaths are likely to be an important component, other causes of excess mortality should not be ignored, including cardiovascular diseases, cancer, and diabetes [3], [4], [7], [8], [22], [31]. Physical health risk assessments and assertive intervention by primary and secondary medical services have been proposed and have resulted in improvements [20], [43]. Continued monitoring of mortality trends in people with mental disorders will be required to evaluate the impact of policy changes as they occur.
What the sources say
- Supportedcites [23] CK Chang, 2010, All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study., BMC Psychiatry source
The Results report that SMRs standardized using London mortality data were comparable to those using England and Wales data. The Discussion states that this sensitivity analysis did not reveal any meaningful differences. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3], [5], [30], [31], [36]–[38]”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Discussion Using a large secondary mental healthcare database in southeast London linked to national mortality returns, we confirmed substantially shortened life expectancies at birth for all serious mental disorder groups investigated compared to national norms. Largest reductions were found for men with schizophrenia, women with schizoaffective disorders, and both men and women with substance use disorders. In previous analyses of these cohorts, raised standardised mortality ratios (SMRs) had been described [23], although the picture was less dramatic because SMRs reflect less well the impact of premature mortality at earlier life stages. In a US study conducted by the Massachusetts Department of Mental Health from 1989 to 1994, service users with SMI were found to have lost 8.8 years of potential life (14.1 years for men and 5.7 for women) on average compared to the general population, a stronger impact for men and weaker impact for women compared to findings from our sample. However, SMI was not specifically defined in the Massachusetts study other than stating “evidence of serious dysfunction” as an inclusion criterion [1], which might explain the discrepancy. A Swedish analysis of national discharges from 1978–82 reported more complex data on life expectations at given ages. For the lowest age described (30 years), subsequent life expectancy associated with schizophrenia was 7.9 years lower in men and 9.5 years lower in women [18] – i.e. similar to the finding for women in our sample but less strong for men. Further international research is clearly required to compare the potential impacts of SMI on life expectancy in different settings since this may provide clues as to systems of care which may help to maximise this. Mortality in SMI is recognised to be raised and underlying causes may be multiple. As well as our own findings, any psychiatric diagnosis was associated with a 65% higher than expected total mortality in a case register study in a British primary care cohort [30]. In the same setting, a three-fold elevated mortality was found for coronary heart disease in young adults with SMI, and a more than two-fold increased mortality of stroke in all age groups [8]. Long-term antipsychotic use and adverse lifestyle choices (e.g. obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3], [19], [20], [22], [31]–[33] and clearly need higher levels of consideration in order to improve health and survival, as well as the better-known risks of suicide and violent deaths. Because the causal pathways between mental disorder and premature mortality are multiple, and because life years lost as an outcome measures not only the effect of an exposure on risk of mortality but also its differential effect across the age range, it is difficult to interpret with certainty the gender variation in findings – i.e. the strongest effects of schizophrenia in men and schizoaffective disorder in women. Clearly the two disorders overlap substantially at a genetic and biological level. It is possible that the impact of co-occurring affective disorder is stronger in women due to specific biological or social vulnerability. However, against this, there was no difference in the impact of bipolar disorder between men and women and the impact of depressive episode/disorder was stronger in men. Alternative explanations may lie in the clinical practice of assigning diagnoses and gender differences here – for example, if there was preferential inclusion in women of severe personality disorders with transient psychotic episodes within this diagnostic group. Further research is clearly required to clarify this issue. Life expectancy is a commonly used indicator for how longevity may be impaired by specific long-term exposures (e.g. smoking, obesity, ethnicity, and socioeconomic status) or chronic states of ill-health or risk (e.g. diabetes mellitus) [12], [13], [15]–[17], [34], and provides an alternative platform to discriminate the influences of different exposures for the purpose of highlighting premature mortality at younger ages in potentially vulnerable groups [25]. It is therefore primarily a measure of impact and should be seen as complementary to more common studies using measures of effect, such as SMR statistics. As a measure, life expectancy analyses provide an important means of communicating impact on survival to policy makers and lay audiences. This approach also allows the impact of different exposures to be compared in a way which cannot be inferred from SMR outputs. As a case in point, considering the impact of other well-recognised exposures and comparing these with the potential impact of SMI, in a Japanese study of life expectancy from age 40, smoking was the most important predictor of six lifestyle related exposures (smoking, alcohol consumption, walking duration, sleep duration, consumption of green leafy vegetables, and obesity), current smoking being associated with around four to five life years lost for both genders [12], [13]. Considering 2005 life expectancy levels in the USA (75.1 years for men and 80.3 years for women), current and previous smoking was associated with 2.5 years lower life expectancy for men and 1.8 years lower life expectancy for women [17]. For British doctors born in 1900–1930 and followed up for fifty years, continued smoking was associated with around 10 years life lost, compared to lifelong non-smokers [16], and in New Zealand Census records in 1996, the gap in life expectancy between current and never smokers was 7.6 years in men and 6.7 for women [15]. Diabetes was reported to reduce life expectancy at age 15 by 1.3 years for men and 2.0 years for women in Canada [14], and a BMI of 40–45 kg/m2 was associated with a 10 year reduction of life expectancy at age 35 compared to a BMI 22.5–25 kg/m2 [35]. The potential impact of having a serious mental illness (or a substance use disorder or a depressive episode requiring secondary care contact) on life expectancy is therefore at least comparable and at worse substantially higher than effects of individual well-recognised exposures, although clearly the mechanisms through which mental disorders are associated with premature mortality will include the effects of these individual risk factors (for example, smoking behaviour, risk of diabetes, etc.) as well as other factors (such as risk of suicide or accidents and direct effects of mental distress on cardiovascular risk). Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3], [5], [30], [31], [36]–[38], although mental health service provision is often focused on preventing more rare outcomes of suicide and violent death [39]–[41]. If improving overall survival is to be considered as an alternative priority, much more efforts are clearly required to address the challenges of improving general health in people with mental disorders through medical services, socioeconomic support, and physical health promotion strategies [19]. Strengths of the study described include the large sample size and nationwide coverage of mortality, as well as the context of complete electronic clinical records. Potential limitations include the secondary healthcare setting; this should present no problem for high penetrance disorders, such as schizophrenia and bipolar disorder, where most cases will have received secondary care input. However, findings for substance use disorders and depressive disorders should be viewed with circumspection since those appearing on a secondary care register are likely to be an unrepresentative (and probably more severe) subset of community cases. Ultimately, the findings for life expectancy should be taken as referring to people with these mental disorders who had made contact with secondary mental health services within the given time period and are not necessarily applicable to all cases in a given community. Diagnostic categories overlapped, but only a minority (5.7%) of people had received more than one mental disorder diagnosis during the surveillance period. Nevertheless, comorbidity between SMI and substance use disorders should not be assumed to be captured as the source data reflected primary diagnoses rather than co-occurrence. Also we did not attempt to capture co-occurring or changing diagnoses which present potentially complex issues for analysis in a secondary care sample and which we felt were beyond the scope of this initial report. Although SLAM is a major academic as well as clinical centre, mental disorders on the Case Register are likely to be broadly generalizable to other urban settings in the UK (the SLAM catchment covers a range of residence areas from inner city to suburban settings but does not include any rural areas). Life expectancy comparisons of regional data to national norms may be problematic. However, in a sensitivity analysis of SMR data, the use of London comparators did not meaningfully change findings [23]. Also, from administrative data, life expectancy at birth for population of the four catchment area boroughs in 2007–09 (ranging from 76.3–79.5 years for males and 81.1–82.9 years for females), were not substantially different to national estimates [42]. Our results demonstrate the substantial impact of serious mental illness on life expectancy and highlight importance of developing strategies to prevent premature mortality among people with SMI and other major mental disorders. Although the prevention of suicides and violent deaths are likely to be an important component, other causes of excess mortality should not be ignored, including cardiovascular diseases, cancer, and diabetes [3], [4], [7], [8], [22], [31]. Physical health risk assessments and assertive intervention by primary and secondary medical services have been proposed and have resulted in improvements [20], [43]. Continued monitoring of mortality trends in people with mental disorders will be required to evaluate the impact of policy changes as they occur.
What the sources say
- Supportedcites [3] A Fagiolini, 2009, The effects of undertreated chronic medical illnesses in patients with severe mental disorders., J Clin Psychiatry source
The Cardiovascular Disease section reports that approximately 59% of excess deaths in a meta-analysis of patients with schizophrenia were attributed to natural causes. The FOR CLINICAL USE section also reports that most excess deaths in a study of patients with bipolar disorder were due to natural causes. These findings support the cited background statement, particularly for the severe mental disorders the paper discusses. (LLM, conf=0.88)
- Partly supportedcites [5] S Brown, 2000, Causes of the excess mortality of schizophrenia., Br J Psychiatry sourceExperimental — accuracy not yet measured
The Natural cause mortality section reports that natural causes accounted for 63% of excess mortality, and Overall mortality says about two-thirds of extra deaths were from natural causes. The study concerns people with schizophrenia; it does not establish the same predominance across mental disorders generally. Page numbers are not provided in the supplied passages. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [30] DN Baxter, 1996, The mortality experience of individuals on the Salford Psychiatric Case Register. I. All-cause mortality., Br J Psychiatry source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Long-term antipsychotic use and adverse lifestyle choices (e.g. obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3], [19], [20], [22], [31]–[33]”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Discussion Using a large secondary mental healthcare database in southeast London linked to national mortality returns, we confirmed substantially shortened life expectancies at birth for all serious mental disorder groups investigated compared to national norms. Largest reductions were found for men with schizophrenia, women with schizoaffective disorders, and both men and women with substance use disorders. In previous analyses of these cohorts, raised standardised mortality ratios (SMRs) had been described [23], although the picture was less dramatic because SMRs reflect less well the impact of premature mortality at earlier life stages. In a US study conducted by the Massachusetts Department of Mental Health from 1989 to 1994, service users with SMI were found to have lost 8.8 years of potential life (14.1 years for men and 5.7 for women) on average compared to the general population, a stronger impact for men and weaker impact for women compared to findings from our sample. However, SMI was not specifically defined in the Massachusetts study other than stating “evidence of serious dysfunction” as an inclusion criterion [1], which might explain the discrepancy. A Swedish analysis of national discharges from 1978–82 reported more complex data on life expectations at given ages. For the lowest age described (30 years), subsequent life expectancy associated with schizophrenia was 7.9 years lower in men and 9.5 years lower in women [18] – i.e. similar to the finding for women in our sample but less strong for men. Further international research is clearly required to compare the potential impacts of SMI on life expectancy in different settings since this may provide clues as to systems of care which may help to maximise this. Mortality in SMI is recognised to be raised and underlying causes may be multiple. As well as our own findings, any psychiatric diagnosis was associated with a 65% higher than expected total mortality in a case register study in a British primary care cohort [30]. In the same setting, a three-fold elevated mortality was found for coronary heart disease in young adults with SMI, and a more than two-fold increased mortality of stroke in all age groups [8]. Long-term antipsychotic use and adverse lifestyle choices (e.g. obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3], [19], [20], [22], [31]–[33] and clearly need higher levels of consideration in order to improve health and survival, as well as the better-known risks of suicide and violent deaths. Because the causal pathways between mental disorder and premature mortality are multiple, and because life years lost as an outcome measures not only the effect of an exposure on risk of mortality but also its differential effect across the age range, it is difficult to interpret with certainty the gender variation in findings – i.e. the strongest effects of schizophrenia in men and schizoaffective disorder in women. Clearly the two disorders overlap substantially at a genetic and biological level. It is possible that the impact of co-occurring affective disorder is stronger in women due to specific biological or social vulnerability. However, against this, there was no difference in the impact of bipolar disorder between men and women and the impact of depressive episode/disorder was stronger in men. Alternative explanations may lie in the clinical practice of assigning diagnoses and gender differences here – for example, if there was preferential inclusion in women of severe personality disorders with transient psychotic episodes within this diagnostic group. Further research is clearly required to clarify this issue. Life expectancy is a commonly used indicator for how longevity may be impaired by specific long-term exposures (e.g. smoking, obesity, ethnicity, and socioeconomic status) or chronic states of ill-health or risk (e.g. diabetes mellitus) [12], [13], [15]–[17], [34], and provides an alternative platform to discriminate the influences of different exposures for the purpose of highlighting premature mortality at younger ages in potentially vulnerable groups [25]. It is therefore primarily a measure of impact and should be seen as complementary to more common studies using measures of effect, such as SMR statistics. As a measure, life expectancy analyses provide an important means of communicating impact on survival to policy makers and lay audiences. This approach also allows the impact of different exposures to be compared in a way which cannot be inferred from SMR outputs. As a case in point, considering the impact of other well-recognised exposures and comparing these with the potential impact of SMI, in a Japanese study of life expectancy from age 40, smoking was the most important predictor of six lifestyle related exposures (smoking, alcohol consumption, walking duration, sleep duration, consumption of green leafy vegetables, and obesity), current smoking being associated with around four to five life years lost for both genders [12], [13]. Considering 2005 life expectancy levels in the USA (75.1 years for men and 80.3 years for women), current and previous smoking was associated with 2.5 years lower life expectancy for men and 1.8 years lower life expectancy for women [17]. For British doctors born in 1900–1930 and followed up for fifty years, continued smoking was associated with around 10 years life lost, compared to lifelong non-smokers [16], and in New Zealand Census records in 1996, the gap in life expectancy between current and never smokers was 7.6 years in men and 6.7 for women [15]. Diabetes was reported to reduce life expectancy at age 15 by 1.3 years for men and 2.0 years for women in Canada [14], and a BMI of 40–45 kg/m2 was associated with a 10 year reduction of life expectancy at age 35 compared to a BMI 22.5–25 kg/m2 [35]. The potential impact of having a serious mental illness (or a substance use disorder or a depressive episode requiring secondary care contact) on life expectancy is therefore at least comparable and at worse substantially higher than effects of individual well-recognised exposures, although clearly the mechanisms through which mental disorders are associated with premature mortality will include the effects of these individual risk factors (for example, smoking behaviour, risk of diabetes, etc.) as well as other factors (such as risk of suicide or accidents and direct effects of mental distress on cardiovascular risk). Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3], [5], [30], [31], [36]–[38], although mental health service provision is often focused on preventing more rare outcomes of suicide and violent death [39]–[41]. If improving overall survival is to be considered as an alternative priority, much more efforts are clearly required to address the challenges of improving general health in people with mental disorders through medical services, socioeconomic support, and physical health promotion strategies [19]. Strengths of the study described include the large sample size and nationwide coverage of mortality, as well as the context of complete electronic clinical records. Potential limitations include the secondary healthcare setting; this should present no problem for high penetrance disorders, such as schizophrenia and bipolar disorder, where most cases will have received secondary care input. However, findings for substance use disorders and depressive disorders should be viewed with circumspection since those appearing on a secondary care register are likely to be an unrepresentative (and probably more severe) subset of community cases. Ultimately, the findings for life expectancy should be taken as referring to people with these mental disorders who had made contact with secondary mental health services within the given time period and are not necessarily applicable to all cases in a given community. Diagnostic categories overlapped, but only a minority (5.7%) of people had received more than one mental disorder diagnosis during the surveillance period. Nevertheless, comorbidity between SMI and substance use disorders should not be assumed to be captured as the source data reflected primary diagnoses rather than co-occurrence. Also we did not attempt to capture co-occurring or changing diagnoses which present potentially complex issues for analysis in a secondary care sample and which we felt were beyond the scope of this initial report. Although SLAM is a major academic as well as clinical centre, mental disorders on the Case Register are likely to be broadly generalizable to other urban settings in the UK (the SLAM catchment covers a range of residence areas from inner city to suburban settings but does not include any rural areas). Life expectancy comparisons of regional data to national norms may be problematic. However, in a sensitivity analysis of SMR data, the use of London comparators did not meaningfully change findings [23]. Also, from administrative data, life expectancy at birth for population of the four catchment area boroughs in 2007–09 (ranging from 76.3–79.5 years for males and 81.1–82.9 years for females), were not substantially different to national estimates [42]. Our results demonstrate the substantial impact of serious mental illness on life expectancy and highlight importance of developing strategies to prevent premature mortality among people with SMI and other major mental disorders. Although the prevention of suicides and violent deaths are likely to be an important component, other causes of excess mortality should not be ignored, including cardiovascular diseases, cancer, and diabetes [3], [4], [7], [8], [22], [31]. Physical health risk assessments and assertive intervention by primary and secondary medical services have been proposed and have resulted in improvements [20], [43]. Continued monitoring of mortality trends in people with mental disorders will be required to evaluate the impact of policy changes as they occur.
What the sources say
- Partly supportedcites [3] A Fagiolini, 2009, The effects of undertreated chronic medical illnesses in patients with severe mental disorders., J Clin Psychiatry sourceExperimental — accuracy not yet measured
The Medication Side Effects section says atypical antipsychotics increase the likelihood of cardiovascular disease, and the lifestyle discussion links inactivity, poor diet, and smoking to coronary heart disease. Our copy does not establish a risk specifically from long-term antipsychotic use or address illicit drug use as a cardiovascular risk factor; it discusses cardiovascular disease rather than cardiovascular events specifically. Page numbers were not available in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [19] P Auquier, 2006, Mortality in schizophrenia., Pharmacoepidemiol Drug Saf source
- Partly supportedcites [20] R Gray, 2009, Physical health and severe mental illness: if we don't do something about it, who will?, Int J Ment Health Nurs sourceExperimental — accuracy not yet measured
In “Why then do our patients die?” (page not provided), Gray identifies obesity, smoking, lack of exercise and poor diet as prevalent lifestyle risks in people with severe mental illness, and says some prescribed medications increase cardiometabolic disease risk. The passage does not specify long-term antipsychotic use or link illicit drug use to cardiovascular events; it mentions drug misuse only as another influence on health. (LLM, conf=0.85)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All the life expectancies at birth for specific mental disorders were significantly different between genders based on their 95% confidence intervals.”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
6 more claims
Create a free account to see all 37 claims and every source verdict.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“people with mental health disorders have a life expectancy eight years less than the general population”
From Change in mental health after smoking cessation: systematic review and meta-analysis (2014) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The reductions of life expectancy among persons with bipolar disorder seem to be slightly smaller: approximately 10 years in a study from London [43], and 13 years in a Danish study made on data similar to the Danish data used in Table 3 [44].”
From Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries. (2013) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This mortality gap translates to a 10-20 year shortened life expectancy 3,4”
From Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis (2016) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This mortality gap translates into a 10-20 year shortened life expectancy (3,4) and appears to be widening (5).”
From Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis (2015) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent study from the United Kingdom (Chang et al. 2011) found that life expectancy was reduced by 14.6 years among persons with schizophrenia.”
From Excess early mortality in schizophrenia. (2014) · cites this paper as Chang et al. 2011
Experimental — accuracy not yet measured
Citations
Cites
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Mortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920 · cited 1×
“. For British doctors born in 1900–1930 and followed up for fifty years, continued smoking was associated with around 10 years life lost, compared to lifelong non-smokers”
BackgroundSchizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881 · cited 1×
“Although the prevention of suicides and violent deaths are likely to be an important component, other causes of excess mortality should not be ignored, including cardiovascular diseases, cancer, and diabetes [3,4,7,8,22,31].”
Background(2006) · Europe PMC (PubMed Central) · Cited by 1,299
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087 · cited 2×
“Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3,5,30,31,36–38], although mental health service provision is often focused on preventing more rare outcomes of suicide and violent death [39–41].”
BackgroundDe Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951
The unhealthy lifestyle of people with schizophrenia
BROWN, S., BIRTWISTLE, J., ROE, L., & THOMPSON, C. (1999) · Psychological Medicine · doi:10.1017/s0033291798008186 · Cited by 874 · cited 1×
“obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3,19,20,22,31–33] and clearly need higher levels of consideration in order to improve health and survival, as well as the better-known risks of suicide and violent dea…”
Background
Cited by
Items 401–500 of 706
Li, H., Chen, C., Chen, Y., Han, B., Chen, Y., Cheng, J., Wang, N., Wang, B., & Lu, Y. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04684-1 · Cited by 11
The European studies on mortality in schizophrenia
Gondek, T. M., Królicka, A., Piotrowski, P., & Kiejna, A. (2015) · Psychiatria Polska · doi:10.12740/pp/37845 · Cited by 10
Ballbè, M., Gual, A., Nieva, G., Saltó, E., & Fernández, E. (2016) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2016.04.017 · Cited by 8
Big data: what it can and cannot achieve
Schofield, P., & Das‐Munshi, J. (2018) · BJPsych Advances · doi:10.1192/bja.2018.15 · Cited by 7
Li, Y., Wen, H., Xu, J., et al. (2019) · Community Mental Health Journal · doi:10.1007/s10597-019-00460-2 · Cited by 8
Chene, M., Rico, M. S., Blanco, C., de Raykeer, R. P., Hanon, C., Vandel, P., Limosin, F., Hoertel, N., CSA Study group, Adès, J., et al. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01426-4 · Cited by 13
“Although no direct comparison can be performed in this study, these results are consistent with the idea that excess mortality among people with psychiatric disorders may persist in late life [7, 72].”
ResultBellass, S., Taylor, J., Han, L., Prady, S. L., Shiers, D., Jacobs, R., Holt, R. I. G., Radford, J., Gilbody, S. M., Hewitt, C. E., et al. (2019) · JMIR Research Protocols · doi:10.2196/13407 · Cited by 9
“They have a reduced life expectancy, living for 15 to 20 years less than the population as a whole, and experience poorer health outcomes [2-5].”
DETERMINANTS OF LIFE EXPECTANCY IN NIGERIA: AN AUTOREGRESSIVE DISTRIBUTED LAG APPROACH
ONWUBE, O., Chukwu, A. B., Ahamba, K. O., Emenekwe, C. C., & Enyoghasim, M. O. (2021) · Journal of Sustainability Science and Management · doi:10.46754/jssm.2021.12.012 · Cited by 10
Willadsen, T. G., Siersma, V., Nicolaisdóttir, D. R., Køster‐Rasmussen, R., Reventlow, S. D., & Rozing, M. P. (2022) · Journal of Multimorbidity and Comorbidity · doi:10.1177/26335565221122025 · Cited by 6
“Severe mental health disorders reduce life expectancy by almost two decades.(44) This could probably be ascribed to several factors such as metabolic side effects of psychotrop medication and unhealthy lifestyle, but also shared genetic factors for the mental health disorders and some somatic conditions.”
BackgroundHsu, C.-C., Liang, C., Tai, Y., & Cheng, S.-L. (2016) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2016.08.011 · Cited by 8
“It serves as the final common pathway to CVD. Evidence suggests that patients with schizophrenia have high rates of obesity and CVD mortality (Hennekens et al., 2005), and their life expectancy is 20 years less than that of the general population (Chang et al., 2011).”
BackgroundWinterton, A., Bettella, F., de Lange, A. G., Haram, M., Steen, N. E., Westlye, L. T., Andreassen, O. A., & Quintana, D. S. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01725-9 · Cited by 7
“INTRODUCTION Schizophrenia (SCZ) and bipolar disorders (BD) are associated with reduced life expectancies [1, 2], partly caused by an increased risk for cardiovascular disease (CVD) [3].”
BackgroundSchizophrenia Spectrum and Other Psychotic Disorders
(2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890425787.x02_schizophrenia_spectrum · Cited by 14
Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review
Paribello, P., Manchia, M., Pinna, F., Isayeva, U., Squassina, A., Pisanu, C., Balderi, L., Contu, M., Pinna, M., & Carpiniello, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054776 · Cited by 6
“Collectively, SMI represents an ill-defined category which has been inconsistently reported in the literature in the field [3] but that, as a bare minimum, comprises conditions such as schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD) [2,3].”
BackgroundPoint prevalence and sex-specific associated factors of depression in Latvian general population
Vinogradova, V. V., Ķīvīte‐Urtāne, A., Vrubļevska, J., & Rancāns, E. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1065404 · Cited by 8
“The life expectancy of patients with depression is approximately 7–10 years shorter than that of people in the general population, which can be explained by both somatic comorbidities (12, 13) and increased suicide risk (13, 14) in patients.”
BackgroundGallagher, D. M., Buckley, M., Kenny, C., Onwudiwe, C., Young, C., Rutledge, J., Grenham, I., & Kilduff (2013) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2013.5 · Cited by 9
“The excess mortality also extends to patients with bipolar disorder, depression and substance-use disorders, although a recent analysis reported that the lowest life expectancies are for men with schizophrenia and women with schizoaffective disorder (Chang et al. 2011).”
BackgroundWhat about treatment of smoking to improve survival and reduce depression?
Taylor, G. M. J., & Munafo, M. R. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30132-9 · Cited by 7
Buhagiar, K., Templeton, G., & Osborn, D. (2020) · European Psychiatry · doi:10.1192/j.eurpsy.2020.22 · Cited by 7
Mörkl, S., Stell, L., Buhai, D.-V., Schweinzer, M., Wagner‐Skacel, J., Vajda, C., Lackner, S., Bengesser, S., Lahousen, T., Painold, A., et al. (2021) · Nutrients · doi:10.3390/nu13030822 · Cited by 60
“This is driving, in part, the high rates of chronic disease and reduced life expectancy [2].”
BackgroundRhee, T. G., Shim, S. R., Nasir, M., McIntyre, R. S., Kaster, T. S., & Wilkinson, S. T. (2025) · BMJ Mental Health · doi:10.1136/bmjment-2025-302083 · Cited by 12
Ede, G., Bernstein, M., Calabrese, L. V., Campbell, I. H., Laurent, N., Palmer, C. M., Sethi, S., & Zupec‐Kania, B. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1749406 · Cited by 9
Browne, J., Rudolph, J. L., Jiang, L., Bayer, T. A., Kunicki, Z. J., Vito, A. N. D., Bozzay, M. L., McGeary, J. E., Kelso, C. M., & Wu, W. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111604 · Cited by 7
Life expectancy in relation to societal development level: significant discordant factors
Matoc, M. S., Stiperski, Z., Matoc, L., & Valožić, L. (2024) · Central European Journal of Public Health · doi:10.21101/cejph.a8162 · Cited by 8
Treating smoking in mental health settings
Britton, J. R. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00102-9 · Cited by 6
Peddie, N., Westbury, T., & Snowden, A. (2020) · Health & Social Care in the Community · doi:10.1111/hsc.13017 · Cited by 11
“…2019), but the relationship between motivation, exercise and mental ill-health is not clear (Bond et al., 2020), and this is important to understand because people with long-term mental health conditions such as depression can have a reduced life expectancy of 7–11 years (Chang et al., 2011).”
BackgroundImplications of COVID-19 Mitigation Policies for National Well-Being: A Systems Perspective
Strelkovskii, N. V., Rovenskaya, E., Ilmola‐Sheppard, L., Bartmann, R., Rein‐Sapir, Y., & Feitelson, E. I. (2021) · Sustainability · doi:10.3390/su14010433 · Cited by 6
Exploring the complex relationship between obesity and mental health: A narrative review
Kar, N., & Kar, S. (2022) · Odisha Journal of Psychiatry · doi:10.4103/ojp.ojp_8_23 · Cited by 8
The Link between OSA and Depression: Another Reason for Integrative Sleep Medicine Teams
Haynes, P. L. (2013) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.2654 · Cited by 6
Carter, M., Fisher, C. M., & Isaac, M. (2013) · SAGE Open · doi:10.1177/2158244013512133 · Cited by 9
“Comorbidity is more chronic, persistent, and disabling than mental illness or addiction alone with comparatively poor outcomes including greatly reduced life expectancy (Chang et al., 2011; Colton & Manderscheid, 2006; Cosci & Fava, 2011; Kessler, 2004a; Withers & Hirsch, 2003).”
BackgroundStupak, R., & Dyga, K. (2018) · Theory & Psychology · doi:10.1177/0959354318802973 · Cited by 7
Campion, J., Taylor, M. J., McDaid, D., Park, A., & Shiers, D. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12787 · Cited by 7
Ballbè, M., Martínez, C., Feliu, A., Torres, N., Nieva, G., Pinet, C., Raich, A., Mondón, S., Barrio, P., Hernández‐Ribas, R., et al. (2019) · Trials · doi:10.1186/s13063-018-3106-5 · Cited by 6
Expected life years compared to the general population
Manevski, D., Gorenjec, N. R., Andersen, P. K., et al. (2023) · Biometrical Journal · doi:10.1002/bimj.202200070 · Cited by 6
“However, different approaches to define or estimate the number of years lost/saved have been proposed in the past (Chang et al., 2011; Gardner & Sanborn, 1990; Nordentoft et al., 2013), which may lead to substantially different answers with the same dataset and bring substantial biases; an overview…”
BackgroundEvaluating Diabetes Care for Patients With Serious Mental Illness Using the Chronic Care Model
Vaez, K., Diegel-Vacek, L., Ryan, C. J., & Martyn-Nemeth, P. A. (2017) · Health Services Research and Managerial Epidemiology · doi:10.1177/2333392817734206 · Cited by 6
“Project Aims The aims of this project were to determine, within the setting of an urban federally qualified health center (FQHC) that provides primary care to patients with SMI, among patients with SMI and diabetes: (1) how well the clinic’s system aligned with the overall CCM components, (2) which components of the C…”
BackgroundEditorial: a new journal in bipolar disorders
Bauer, M. (2013) · International Journal of Bipolar Disorders · doi:10.1186/2194-7511-1-1 · Cited by 6
“The life expectancy of patients with bipolar disorder is reduced by more than 10 years (Chang et al. 2011), likely due to medical comorbidity, high suicide rates and adverse lifestyles.”
BackgroundStewart, R. J., Broadbent, M. T. M., & Das‐Munshi, J. (2020) · medRxiv · doi:10.1101/2020.07.13.20152710 · Cited by 6
Self-citationStewart, R. J., Martin, E., Bakolis, I., Broadbent, M. T. M., Byrne, N., & Landau, S. (2020) · medRxiv · doi:10.1101/2020.09.26.20202150 · Cited by 6
Self-citationInitiatives to improve physical health for people in community-based mental health programs
Bartlem, K. M., Fehily, C. M. C., Wynne, O., Gibson, L. E., Lodge, S., Clinton‐McHarg, T., Dray, J., Bowman, J., Wolfenden, L., & Wiggers, J. (2020) · doi:10.57022/conj2912 · Cited by 6
Jensen, K. T., Jønsson, A. B. R., Due, T. D., Siersma, V., Brodersen, J., Bissenbakker, K. H., Martiny, F., Davidsen, A. S., Kjellberg, P. K., Doherty, K., et al. (2023) · BMC Family Practice · doi:10.1186/s12875-023-02141-2 · Cited by 6
Understanding and improving the quality of primary care for people in prison: a mixed-methods study
Bellass, S., Canvin, K., Farragher, T. M., McLintock, K., Wright, N. M. J., Hearty, P., Seanor, N., Cunningham, M., Foy, R., & Sheard, L. (2024) · Health and Social Care Delivery Research · doi:10.3310/grfv4068 · Cited by 9
Correll, C. U., Cutler, A. J., Laliberté, F., Germain, G., MacKnight, S. D., Boudreau, J., Wade, S. W., Nabulsi, N. A., Nguyen, H., & Parikh, M. (2025) · Annals of General Psychiatry · doi:10.1186/s12991-024-00542-w · Cited by 5
“Individuals with serious mental illness such as bipolar I disorder (BP-I), schizophrenia, or major depressive disorder (MDD) have a life expectancy 8–28.5 years shorter than the general population [1, 2].”
InfluentialLawrence, E. G., Zahid, U., Thomson, A. C., Lau, R. S., Havers, L., Biotti, F., Pereira, M. A., Freestone, M. C., González-Calvo, I., Elliott, B., et al. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf128 · Cited by 12
Mental health, smoking and poverty: benefits of supporting smokers to quit
Salt, V., & Osborne, C. (2020) · BJPsych Bulletin · doi:10.1192/bjb.2020.88 · Cited by 5
ter Braake, J. G., Fleetwood, K., Vos, R. C., Blackbourn, L. A. K., McGurnaghan, S. J., Wild, S. H., & Jackson, C. (2024) · Diabetologia · doi:10.1007/s00125-024-06111-w · Cited by 8
González, J. L. S., Sánchez-Gil, A., Vicente-Muñoz, E., Navarro‐López, V., Martín‐Vallejo, J., & Pérez, J. M. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.04.001 · Cited by 10
Conway, C. R., Rush, A. J., Gordon, C., Preskorn, S., Sackeïm, H. A., Aaronson, S. T., McIntyre, R. S., Lee, Y.-C. (., Shy, O., Tran, Q., et al. (2025) · Journal of Mood and Anxiety Disorders · doi:10.1016/j.xjmad.2025.100121 · Cited by 6
Assessment of mental and physical health outcomes over time in an integrated care setting
Bhatta, D., Sizer, M. A., Acharya, B., & Banjara, D. (2025) · BMC Family Practice · doi:10.1186/s12875-025-02876-0 · Cited by 11
Putative effects of cannabidiol in depression and synaptic plasticity
Joca, S. R. L., Silote, G. P., Sartim, A. G., Sales, A. J., Guimarães, F. S., & Wegener, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817933-8.00052-9 · Cited by 7
Improving the life expectancy of people with serious mental illness
Chang, C. (2012) · British Journal of Hospital Medicine · doi:10.12968/hmed.2012.73.3.126 · Cited by 5
Self-citationJones, J., McBain, H. B., Lamontagne-Godwin, F., Mulligan, K., Haddad, M., Flood, C., Thomas, D., & Simpson, A. (2016) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12311 · Cited by 5
“A smaller case register study with 31,719 people with SMI conducted in South London (Chang et al, 2011), found that the people with SMI died prematurely by up to 17.5 years compared to people without SMI.”
InfluentialMultimorbidity in people with mental illness: translating evidence to practice
Gray, R. J., Hughes, E. A., & Bressington, D. T. (2016) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12316 · Cited by 5
Chaturvedi, J., Sabbah, W., Gallagher, J. E., Turner, J. E., Curl, C., & Stewart, R. J. (2021) · European Journal Of Oral Sciences · doi:10.1111/eos.12752 · Cited by 4
“Over 150 peer-reviewed research papers have been published to date using SLaM's CRIS data resource, including a number focusing on physical health outcomes in people with mental disorders [11,16-19].”
Self-citationWilliams, J., Fairbairn, E., McGrath, R., Bakolis, I., Healey, A., Akpan, U., Mdudu, I., Gaughran, F., Sadler, E., Khadjesari, Z., et al. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-021-00854-8 · Cited by 7
McMahen, C., Wright, K. E., Stanton, R., Lederman, O., Rosenbaum, S., McKeon, G., & Furzer, B. J. (2021) · Mental health and physical activity · doi:10.1016/j.mhpa.2021.100438 · Cited by 9
Blunted neuroeconomic loss aversion in schizophrenia
Currie, J., Waiter, G. D., Johnston, B. A., Feltovich, N., & Steele, J. D. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147957 · Cited by 5
Elevation of C-reactive protein in adolescent bipolar disorder vs. anxiety disorders
Whitney, M. S., Scott, S. L., Perez, J. A., Barnes, S., & McVoy, M. K. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.09.019 · Cited by 6
Le tabagisme en psychiatrie : réalités et implications pour sa prise en charge
Ketterer, F., Roelandt, J.-L., & Chevreul, K. (2022) · Santé Publique · doi:10.3917/spub.225.0643 · Cited by 6
Physical health in psychiatric patients
Byrne, P. (2018) · Medicine · doi:10.1016/j.mpmed.2018.09.002 · Cited by 5
Substance misuse in the older person: setting higher standards
CROME, I. B. (2013) · Clinical Medicine · doi:10.7861/clinmedicine.13-6-s46 · Cited by 6
Swistak, M. Z., Sookoo, S., & Jewell, T. (2024) · Issues in Mental Health Nursing · doi:10.1080/01612840.2024.2341049 · Cited by 8
“…public health impact: reduced access to healthcare (Memon et al., 2016), higher mortality rates (Mansour et al., 2020), reduced life expectancy (Chang et al., 2011; Chesney et al., 2014), exclusion from employment (Silver, 2017), greater risk of targeted violence (Clement et al., 2011),…”
BackgroundBrown, M., Tassie, E., Carlisle, S., Covshoff, E., Ronaldson, A., Williams, J., Smith, S. M., Trevillion, K., Hughes, E. A., & Heslin, M. (2025) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-025-02844-0 · Cited by 12
“This contributes to people with SMI having a reduced life expectancy compared to the general population of up to almost 18 years in some groups [3].”
Saitoh, K., Lajnef, M., Boukouaci, W., André, M., Andrieu, C., Aouizerate, B., Barau, C., Bouassida, J., Capdevielle, D., Chéreau, I., et al. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116557 · Cited by 4
Park, J. S., Kim, S., Jeong, D.-H., Choi, J. P., Jeong, H.-Y., Park, A. J., Kim, Y. S., Lee, J., & Kim, S. H. (2025) · Schizophrenia · doi:10.1038/s41537-025-00680-4 · Cited by 4
“Women with schizophrenia have a longer life expectancy than men 30,31 : this may result in prolonged exposure to dementia risk factors and a greater cumulative risk of dementia.”
Guo, A., Ullah, O., Zeb, A., Hussain, S., & Din, N. U. (2024) · Journal of International Development · doi:10.1002/jid.3940 · Cited by 5
Attoe, C., Retter, S., Minster, R., & Parish, S. (2019) · BMJ Simulation & Technology Enhanced Learning · doi:10.1136/bmjstel-2019-000505 · Cited by 4
“It's the one thing they have left”: smoking, smoking cessation and mental health
Stockings, E., Metse, A. P., & Taylor, G. M. J. (2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.10003420 · Cited by 4
La réappropriation des voix : mésententes et malentendus dans le champ des hallucinations
Braun, A., & Évrard, R. (2022) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2022.05.005 · Cited by 5
Schizophrenia as a Public Health Problem
Evans, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-29042-8_1 · Cited by 7
Silva, L., Siena, A., Yuzawa, J. M. C., Torresi, J. L. D. B., Ziroldo, A. R., & Rosenstock, T. R. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.04.027 · Cited by 5
Hayward, M., Berry, K., Bremner, S. A., Cavanagh, K., Dodgson, G., Fowler, D. G., Gage, H., Greenwood, K., Hazell, C. M., Bibby-Jones, A.-M., et al. (2023) · Trials · doi:10.1186/s13063-023-07611-7 · Cited by 5
“The symptoms of psychosis such as paranoid delusions and hearing voices (hereafter referred to as distressing voices) cause significant distress and disability and contribute to an increased risk of physical health problems and early mortality [2], and suicide rates up to twelve times greater than the general populati…”
BackgroundDunn, M., Peisah, C., & Wand, A. P. F. (2023) · Internal Medicine Journal · doi:10.1111/imj.16294 · Cited by 3
Lambert, T. J. R., Jay, M., Hennessy, E., Smith, K., & Sureshkumar, P. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s479281 · Cited by 5
Modern Psychiatry: from Theory to Practice
Петрова, Н. Н. (2024) · Personalized Psychiatry and Neurology · doi:10.52667/2712-9179-2024-4-4-11-25 · Cited by 6
Alexander, L., Beck, K., Bocharova, M., Young, A. H., Stewart, R. J., Carter, R., & Mueller, C. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2025.45 · Cited by 6
Self-citationD, P. S. M., & Kathol, R. G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0688-8 · Cited by 5
Pressanto, C., Scholtz, S., & Ali, N. (2022) · BJPsych Bulletin · doi:10.1192/bjb.2022.31 · Cited by 3
Brazel, M., Allison, S. C., Bastiampillai, T. J., et al. (2022) · Australasian Psychiatry · doi:10.1177/10398562221135492 · Cited by 4
“This is likely due to the increased overall morbidity, and mortality associated with these disorders.(9) As age increased, neurocognitive conditions such as dementia became more common as a principal diagnosis for ambulatory episodes, possibly explaining the lower improvement rate after ambulatory OPMHS episodes.”
BackgroundEstimating expected years of life lost of psychiatric disorders in Taiwan: A Nationwide cohort study
Chiu, Y., Huang, W., Wang, S., Wu, M., Chen, Y., Hsu, C., & Wu, C. (2024) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2024.08.006 · Cited by 4
Risk of acute pancreatitis among people with severe mental illness
Vithayathil, M. K., Chang, C., Shetty, H., & Stewart, R. J. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.052 · Cited by 4
Self-citationDiabetes self-management in people with severe mental illness
McBain, H. B., Mulligan, K., Haddad, M., Flood, C., Jones, J., Chapman, J., Hilton, N., & Simpson, A. (2014) · City Research Online (City University London) · Cited by 5
Riesgo suicida y desesperanza en pacientes psiquiátricos hospitalizados
Montaño, S. H., Zableh, A. V., Caamaño, B. H., & Ospino, G. A. C. (2014) · Pensando Psicología · doi:10.16925/pe.v10i17.783 · Cited by 6
“…el riesgo suicida (rs) hasta en un 40% más que el estimado en la población general (Balhara y Verma, 2012; Cañón, 2011; Capasso et al., 2008; Chang et al., 2011; De Hert et al., 2011; Fuentes et al., 2009; Laursen, 2011; López, López y López, 2008; Mojica, Sáenz y Rey-Anacona, 2009;…”
BackgroundLassenius, O., Arman, M., Söderlund, A., & Gustin, L. W. (2014) · Issues in Mental Health Nursing · doi:10.3109/01612840.2014.901448 · Cited by 12
“…of a serious nature, such as diabetes, coronary heart disease, cancer, and respiratory and endocrine disease (Osborn, Nazareth, & King, 2007; Von Hausswolff-Juhlin, Bjarteit, Lindstrom, & Jones, 2009) and may lead to an increased risk of premature death (Chang et al., 2011; Tiihonen et al., 2009).”
BackgroundKertes, J., Stein-Reisner, O., Grunhaus, L. J., & Neumark, Y. D. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1942057 · Cited by 4
“Life expectancy among persons with serious mental illness (SMI) is 10-30 years lower than the general population, depending on sex and diagnosis (Chang et al., 2011; Hjorthøj et al., 2017; Laursen, 2011; Saha et al., 2007).”
BackgroundPsychiatric Disorders and Diabetes
Holt, R. I. G., & Citrome, L. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch57 · Cited by 5
Making Sense of Normative Functions and Information in Neurobiological Systems
Kraemer, D. M. (2012) · DukeSpace (Duke University) · Cited by 4
Langkilde, K., Nielsen, M. H., Damgaard, S. N., Møller, A., & Rozing, M. P. (2025) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2025.01.013 · Cited by 4
Vishwakarma, A., Pankaj, Deep, R., Kumaran, S. S., & Sharan, P. (2025) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry_966_24 · Cited by 4
Wu, Y., Zang, S., Wu, Z., & Huang, J. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1722760 · Cited by 3
Patient and public involvement in integrated psychosocial care
Vassiliadou, I., Tolani, E., Ip, L., Smith, A. R., & Nadal, I. P. (2019) · Journal of Integrated Care · doi:10.1108/jica-06-2019-0027 · Cited by 4
Relationship between Spirituality and Acceptance of Illness Level in Bipolar Patients
Atsira, O. P., Yuliati, E., Atika, A., Abdurachman, A., & Maramis, M. M. (2020) · Kesmas National Public Health Journal · doi:10.21109/kesmas.v15i3.3432 · Cited by 5
Common Psychiatric Disorders in the Renal Patient
Kulikowski, J. D., Payne, S. C., & Hategan, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-84740-1_10 · Cited by 5
Risk of retinal disease and visual impairment in individuals with psychiatric disorders
Chu, J., Shaia, J. K., Jeong, H., Singh, R. P., & Talcott, K. E. (2025) · Eye · doi:10.1038/s41433-025-03851-w · Cited by 5
“As the average life expectancy in individuals with schizophrenia is also shorter than in individuals with BD and MDD, the decreased likelihood of recorded retinal disease diagnoses in individuals with schizophrenia may also be explained by a Neyman bias [ 50, 51].”
Rauchfreie Psychiatrie: Eine Bestandsaufnahme
Linhardt, A., Haider, R., Rampeltshammer, V., Kröger, C. B., & Rüther, T. (2017) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0043-120667 · Cited by 3
Kibitov, A. O., Mazo, G. E., Kasyanov, E. D., Gorbunova, A. P., Rukavishnikov, G. V., & Незнанов, Н. Г. (2024) · Psikhiatriya · doi:10.30629/2618-6667-2024-22-2-54-65 · Cited by 4
The implementation of exercise therapy within hospital-based mental healthcare: Delphi study
McMahen, C., Wright, K. E., Jackson, B., Stanton, R., Lederman, O., McKeon, G., Rosenbaum, S., & Furzer, B. J. (2024) · BJPsych Open · doi:10.1192/bjo.2024.717 · Cited by 5
“1,5 Life expectancy is typically reduced by 10 – 20 years for those with severe mental illness, 3,6,7 with a substantial contribution from premature mortality due to physical disease, including cardiovascular disease and metabolic syndrome.”
Mitrović, D., Savić, I., & Janković, R. (2017) · Vojnosanitetski pregled · doi:10.2298/vsp170304132m · Cited by 3
Consumers With Serious Mental Illness Perspectives on Care Integration: Preparation for Integration
Fisher, K. M., Weissinger, G., O’Rorke, R., Edwards, E., & Diamond, G. S. (2022) · Journal of the American Psychiatric Nurses Association · doi:10.1177/10783903221091974 · Cited by 14
“Their high prevalence and severity of medical conditions, increased substance abuse (Mental Health Services Administration, 2012), and other disparities all contribute to an estimated 10- to 20-year shorter life expectancy (Chang et al., 2011; Nordentoft et al., 2013).”
BackgroundPromoting mental health in men
Haddad, M. (2013) · Nursing Standard · doi:10.7748/ns2013.03.27.30.48.e7203 · Cited by 7
“Studies of the life expectancy of people with mental health disorders have estimated 17 life years lost for substance misuse and 10-15 years for schizophrenia, compared with the general population (Chang et al 2011).”
Hardy, S. (2015) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12236 · Cited by 3
“This is because life expectancy in this group is reduced by 12–19 years (Chang et al. 2011, Laursen 2011).”
BackgroundTremain, D., Freund, M., Wye, P. M., Bowman, J., Wolfenden, L., Dunlop, A. J., Bartlem, K. M., Lecathelinais, C., & Wiggers, J. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020042 · Cited by 3
“Insufficient physical activity (Get Healthy) 1 (2) 1 (2) 0.”
Crawford, M., Huddart, D., Craig, E., Zalewska, K., Quirk, A., Shiers, D., Strathdee, G., & Cooper, S. J. (2019) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.162 · Cited by 3
Metadata
- Authors
- Chang, C.-K., Hayes, R. D., Perera, G., Broadbent, M. T. M., Fernandes, A. C., Lee, W. E., Hotopf, M., & Stewart, R.
- Affiliations
- King's College London (GB)
- South London and Maudsley NHS Foundation Trust (GB)
- Corresponding author
- Chang, Chin-Kuo
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-05-18
- Volume
- 6
- Issue
- 5
- Pages
- e19590
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3097201
- OpenAlex
- W2010135111
- Cited by
- 714
- References
- 44
- Citations by year
- 2026: 17 · 2025: 38 · 2024: 42 · 2023: 45 · 2022: 68 · 2021: 54 · 2020: 62 · 2019: 53 · 2018: 54 · 2017: 46 · 2016: 65 · 2015: 50 · 2014: 52 · 2013: 38 · 2012: 24
- FWCI
- 51.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Funders
- South London and Maudsley NHS Foundation Trust
- National Institute for Health and Care Research
- King's College London
- Medical Research Council
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Keywords
- life expectancy at birth, severe mental illness, mortality gap, premature mortality, schizophrenia, schizoaffective disorder, bipolar disorder, substance use disorders, depressive disorders, years of life lost, sex differences, secondary mental health care, South London and Maudsley NHS Foundation Trust
- MeSH terms
- Adolescent, Adult, Aged, Mental Disorders, Demography, Female, Humans, Life Expectancy, London, Male, Mental Health, Middle Aged, Registries, Wales, Age Distribution, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
